Header
For Healthcare Professionals
moa

JARDIANCE works by inhibiting SGLT2

JARDIANCE works by inhibiting SGLT2
JARDIANCE works by inhibiting]
JARDIANCE works by inhibiting]
JARDIANCE acts independently of beta-cell dysfunction and/or insulin resistance

CKD=chronic kidney disease; SGLT2=sodium glucose co-transporter 2.

For more information, please see Prescribing Information.

Quick links

Reference

  1. Häring HU, Merker L, Seewaldt-Becker E, et al; EMPA-REG MET Trial Investigators. Empagliflozin as add-on to metformin in patients with type 2 diabetes: a 24-week, randomised, double-blind, placebo-controlled trial. Diabetes Care. 2014;37(6):1650-1659.

Disclaimer

Picture/s used in this communication is/are of professional actors/models, used for representation/creative purposes, and are not of any actual patient or healthcare professional. Any resemblance to persons, living or dead is coincidental. Boehringer Ingelheim India Pvt. Ltd. neither owns the images nor is affiliated with the actors/models.